iCARE DOA 3 Panels (Configurable) Rapid Screen Test by Jal Medical
Unparalleled Drug Screening Accuracy
Jal Medical proudly presents the iCARE DOA 3 Panels (Configurable) Rapid Screen Test, a cutting-edge solution in the Drug of Abuse (DOA) Rapid Screen Test Kit category. Our product is a rapid, qualitative, and competitive binding immunoassay designed for the determination of configured drugs and their metabolites in urine, surpassing the cutoff level of 50ng/mL. The test is not meant for monitoring drug levels but excels in screening urine for the presence of configured drugs and their metabolites.
iCARE DOA 3 Panels Rapid Screen Test Key Features:
- Conformance to International Standards: Our iCARE DOA 3 Panels Rapid Screen Test adheres to the rigorous standards set by the USA, Europe, and International drug of abuse test standards, ensuring reliability and accuracy in results.
- Versatile Design Specifications: With a variety of design specifications available, you can choose the configuration that best suits your requirements, providing flexibility and customization.
- High Specificity: Boasting high specificity, our test ensures accurate detection, reducing the chances of false positives and negatives.
- User-Friendly: The iCARE DOA 3 Panels Rapid Screen Test is exceptionally easy to use, providing rapid results within just 5 minutes, making it a convenient and efficient choice for various settings.
- Suitable for Point-of-Care Testing (POCT): Compact and easy to carry, this test is designed for Point-of-Care Testing, allowing healthcare professionals to administer it conveniently in diverse environments.
- Broad Spectrum Testing: The test covers a comprehensive range of chemicals, including AMP, BAR, BZO, BUP, COC, MDMA, KAN, THC, MTD, OPI, OCD, PCP, and TCA, ensuring a thorough screening process.
- Certified and Approved: Our product comes with certifications from CE, FDA, and 510K for most similar products, guaranteeing its quality and reliability.
Technical Specifications of DOA 3 Panels Rapid Screen Test:
- Model Name: Refer to the catalogue for detailed specifications.
- Packing: Available in 50T and 100T per box for flexible usage.
- Specimen: Designed for urine testing.
- Format: Panel configuration for optimal testing conditions.
- Type of Test: Combination of any 3 among Amphetamine (AMP), Barbiturates (BAR), Benzodiazepines (BZO), Buprenorphine (BUP), Cocaine (COC), Ecstasy (MDMA), Ketamine (KAN), Marijuana (THC), Methadone (MTD), Opiate (OPI), Oxycodone (OCD), Phencyclidine (PCP), and Tricyclic Antidepressant (TCA).
- Specificity: 100%
- Sensitivity: 90%
- Minimum Order Quantity (MOQ): 2,000 units
- Shelf Life: 24 months from the date of production.
- Private Labelling: Available with a minimum order quantity of 5,000 units.
Global Reach
Jal Medical takes pride in supplying the iCARE DOA 3 Panels Rapid Screen Test to 57 African countries, including Nigeria, Egypt, Kenya, South Africa, and more. We also extend our services to Caribbean countries and Central Asian nations, reaffirming our commitment to providing top-notch healthcare solutions globally. Choose Jal Medical for unparalleled quality, accuracy, and reliability in drug screening.